Lipopolysaccharide-Induced Depression-Like Behaviors Is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative Stress
- 23 March 2020
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 105 (9-10), 550-560
- https://doi.org/10.1159/000505132
Abstract
Depression is a common disease that afflicts one in 6 people. Numerous hypotheses have been raised in the past decades, but the exact mechanism for depression onset remains obscure. Recently, the neuroinflammatory response and oxidative stress are being attracted more and more attention due to their roles in depression pathogenesis. The inhibition of neuroinflammatory response and oxidative stress is now considered a potential strategy for depression prevention and/or therapy. Sodium butyrate (SB) is a sodium form of the endogenous butyrate. It can inhibit proinflammatory responses and oxidative stress in different models of disease. In the present study, we investigated the effect of SB on lipopolysaccharide (LPS)-induced depression-like behaviors, neuroinflammatory response, and oxido-nitrosative stress in the hippocampus and prefrontal cortex in C57BL6/J mice. Our results showed that 10 days of SB pretreatment at the dose of 300 but not 100 mg/kg markedly ameliorated LPS (0.83 mg/kg)-induced depression-like behaviors in the tail suspension test, forced swimming test, and sucrose preference test. Further analysis showed that 10 days of SB pretreatment not only prevented LPS-induced increases in proinflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, in the hippocampus and prefrontal cortex but also prevented LPS-induced enhancement of oxido-nitrosative stress. Taken together, these results demonstrate that SB is such an agent that could be used to prevent depression onset and/or progression, and inhibition of neuroinflammatory response and oxido-nitrosative stress may be a potential mechanism for its antidepressant actions.Keywords
This publication has 45 references indexed in Scilit:
- Histone deacetylase inhibitors suppress immune activation in primary mouse microgliaJournal of Neuroscience Research, 2013
- Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase InhibitorScience, 2013
- Butyrate Histone Deacetylase InhibitorsBioResearch Open Access, 2012
- Paroxetine for the treatment of depression: a critical updateExpert Opinion on Pharmacotherapy, 2012
- Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in miceInternational Immunopharmacology, 2012
- Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene–environment interactions, and epigeneticsExperimental Neurology, 2011
- D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's DiseasePLOS ONE, 2011
- Sensorimotor modulation of mood and depression: An integrative reviewBehavioural Brain Research, 2010
- Histone deacetylase inhibitorsEuropean Journal of Medicinal Chemistry, 2005
- Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophyHuman Molecular Genetics, 2004